nn

Hot Keywords
Creutzfeldt-jakob disease Alzheimer's disease Central nervous system Autoimmune disease Astrocyte Autoimmunity Bipolar disorder Cerebrospinal fluid Brain Brain injury Brain tumor Depression Encephalitis

Top
About the Journal

Neuroimmunology and Neuroinflammation (NN) is an open access, peer-reviewed and quarterly online journal. NN aims to provide consensus guidelines and standards for neurologists in Asia-Pacific regions as well as offer advanced research outputs and techniques to clinicians and physicians in the field of neuroscience and neurology worldwide.

Aims and Scope

The journal focuses on neuroimmunology and neuroinflammation, and the coverage extends to other basic and clinical studies related to neuroscience, including molecular biology, psychology, pathology, physiology, endocrinology, pharmacology, oncology, etc. Articles of clinical interest and with clinical implications will be given preference. The journal specializes in the publication of articles dealing with epidemiological investigation and consensus guidelines and standards in the Asia-Pacific region. Articles in the following areas are especially welcome:
  • Mechanisms of regulation of the immune and inflammatory response by the central nervous system;
  • Changes in relevant immune and inflammatory reactions at the cellular and molecular level during the development of nervous system diseases;
  • Clinical research on immune and inflammatory diseases of the nervous system.

The journal publishes the following types of articles: Original Article, Review, Guideline, Meta-Analysis, Systematic Review, Editorial, Case report, Commentary, etc. Manuscripts with videos are also welcome.

Ownership

The journal is owned by OAE Publishing Inc.

Publishing Model

Gold open access. All articles published by NN are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.

Copyright and License to Publish

Articles in NN had been published under Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) by October 2017, whereas the Creative Commons Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting NN, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Editorial Policies

All manuscripts submitted to NN should adhere to NN's Editorial Policies.

Peer Review

The journal adheres to a rigorous peer review process and operates single-blind peer review. For more details, please refer to Editorial Process and Peer Review Guidelines.

Publication Ethics Statement

Neuroimmunology and Neuroinflammation is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Neuroimmunology and Neuroinflammation take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Journal Information and Statistics

  • Launch date: June 27, 2014 
  • Publication model: Open access 
  • ISSN 2349-6142 (Online), ISSN 2347-8659 (Print)
  • Digital archive: Portico  
  • Frequency: Quarterly published (June, 2014-December, 2019 monthly)
  • DOI: 10.20517/2347-8659 

Indexing/Abstracting

Contact

Please visit Contact Us for details about different queries.

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties